TY - JOUR T1 - Hypocalcemia and Acute Pulmonary Embolism Hospitalizations in the United States: Highlights from the propensity matched 2017 Nationwide Inpatient Sample JF - medRxiv DO - 10.1101/2021.07.22.21260999 SP - 2021.07.22.21260999 AU - Mukunthan Murthi AU - Hafeez Shaka AU - Zain El-amir AU - Sujitha Velagapudi AU - Abdul Jamil AU - Farah Wani AU - Ramtej Atluri AU - Akshay Kumar AU - Asim Kichloo Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/07/25/2021.07.22.21260999.abstract N2 - Acute pulmonary embolism (PE) is a common cause for hospitalization associated with significant mortality and morbidity. Disorders of calcium metabolism are a frequently encountered medical problem. The effect of hypocalcemia is not well defined on the outcomes of patients with PE. We aimed to identify the prognostic value of hypocalcemia in hospitalized PE patients utilizing the 2017 Nationwide Inpatient Sample (NIS). In this retrospective study, we selected patients with a primary diagnosis of Acute PE using ICD 10 codes. They were further stratified based on the presence of hypocalcemia. We primarily aimed to compare in-hospital mortality for PE patients with and without hypocalcemia. In the 2017 NIS, 187,989 patients had a principal diagnosis of acute PE. Among the above study group, 1565(0.8%)had an additional diagnosis of hypocalcemia. 12.4% of PE patients with hypocalcemia died in the hospital in comparison to 2.95% without hypocalcemia. On multivariate regression analysis, PE and hypocalcemia patients had 4 times higher odds (aOR-4.03, 95% CI 2.78-5.84, p<0.001) of in-hospital mortality compared to those with only PE. We observed a similarly high odds of mortality(aOR=4.4) on 1:1 propensity-matched analysis. The incidence of acute kidney injury (aOR=2.62, CI 1.95-3.52, p<0.001), acute respiratory failure (a0R=1.84, CI 1.42-2.38, p<0.001), sepsis (aOR=4.99, CI 3.08-8.11, p<0.001) and arrhythmias (aOR=2.63, CI 1.99-3.48, p<0.001) were also higher for PE patients with hypocalcemia. Thus, PE patients with hypocalcemia have higher in-hospital complications and mortality than those without hypocalcemia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NoneAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNone ER -